Skip to main content

The Carolina Endometrial Cancer Study (CECS) provides important data for integrating tumor biology, lifestyle, social environment, cancer treatment, and other factors to identify contributors to outcomes and inform potential areas for intervention or development.

 

Study Design

The Carolina Endometrial Cancer Study (CECS) is a prospective cohort that uses rapid case ascertainment in collaboration with the North Carolina Central Cancer Registry to identify women with newly diagnosed endometrial cancer living in North Carolina. Enrollment began in January 2021 and is ongoing. Eligible participants are sampled by age, race, and geographic region.

 

Recruitment Eligibility

  • Female adults aged 20 to 80 at time of diagnosis
  • Are fluent in English
  • Residents of any of the 100 counties of North Carolina at time of diagnosis
  • Newly diagnosed with endometrial cancer since January 1, 2020

 

Informed Consent

All participants provided informed consent in English prior to participation. CECS consent materials can be accessed below:

Consent to Participate in Research – CECS

Consent for Biological Specimens – Saliva/Tumor

Consent Addendum for Unencrypted Communication

Consent To Participate in Research – Home Visit Sub-Study

Consent for Biological Specimens – Stool/Vaginal

 

Questionnaires

Participants are asked to complete surveys on factors related to endometrial cancer risk and prognosis, survivorship, and recurrence at enrollment and approximately 18- and 36-months after diagnosis. Annotated survey instruments and can be accessed below:

Enrollment Questionnaire

18-month Questionnaire

36-Month Questionnaire

60-Month Questionnaire

Home Visit Pilot Questionnaire

 

 

Medical Records

Participants are asked for consent to retrieve medical records for initial endometrial cancer treatment and any recurrence. Medical record abstraction forms can be accessed below:

Medical Record Abstraction Form

Medical Records Abstraction Data Dictionary

Biospecimens

Participants are asked for consent to obtain tumor samples from their initial endometrial cancer diagnosis and to provide a mail-based saliva sample for germline DNA. A subset of 50 CECS participants within 90 miles of UNC additionally provided self-sampled stool and vaginal microbiome samples as part of a pilot study. Detailed information can be found here: https://unclineberger.org/cecs/biospecimens/

Centralized Pathology Review Form

Centralized Pathology Review Data Dictionary

Approved Project List

 

If you are interested in using CECS data for your project, please complete the following forms and email to cecs@unc.edu.

CECS Proposal Form (LOI)

Authorship Proposal Guidelines Form

Data Use Agreement Form

LCCC Rapid Case Ascertainment Acknowledgement 

Title Investigator(s) Institution Approved
Assessing Financial Toxicity and Quality of Life in Endometrial Cancer Survivors: A Secondary Analysis of the Carolina Endometrial Cancer Study Megan Wohlfarth UNC-Chapel Hill 01/24/2024
Lymphedema self-assessment among endometrial cancer survivors  Jordyn Brown UNC-Chapel Hill 02/20/2024
Multilevel social determinants of health-related quality of life among endometrial cancer survivors in North Carolina  Jordyn Brown UNC-Chapel Hill 02/20/2024
Pre-Diagnosis Symptoms Reported Among Endometrial Cancer Survivors  Meredith Wise UNC-Chapel Hill 04/29/2024
Patient-reported frailty 3-years after an endometrial cancer diagnosis by race and body mass index Vanessa Slater UNC-Chapel Hill 07/24/2025
Impact of cancer-related employment disruption on financial toxicity and quality of life in the Carolina Endometrial Cancer Study Brianna Taffe UNC-Chapel Hill 09/09/2025
Racial Disparities in Patient Experience and Provider Practices: An Evaluation of NCCN-recommended Survivorship Assessment in Carolina Endometrial Cancer Study Mu Jin UNC-Chapel Hill 09/17/2025